Genesys Spine is partnering with Pria Healthcare to improve patient coverage for its sacroiliac joint fusion products.

Spine devicemaker TeDan Surgical released a surgical access system designed for anterior approaches.

Smith+Nephew saw a slight revenue uptick in the first quarter of 2022; however, its sports medicine and joint repair segment jumped with double-digit growth.

Daniel Scavilla is the new CEO of Globus Medical, succeeding Dave Demski, who stepped down to pursue other opportunities after 20 years with the company.

Stryker on April 28 posted $4.3 billion in first-quarter net sales and saw 5.1 percent growth in its orthopedics and spine business.

Camber Spine received a notice of allowance from the U.S. Patent and Trademark Office for its Variant Retractor.

The U.S. Patent and Trademark Office has granted patents to multiple innovative spine and orthopedic devices since 2020.

A milestone in an artificial disc trial and seven more updates from spine and orthopedic device companies in the last week:

CTL Amedica was recently granted a U.S. patent for its Klimt expandable lumbar interbody fusion cage design.

Bioventus intends to sell $415 million worth of senior notes in a private offering. 

Medtronic promoted Laura Mauri, MD, to serve as chief scientific, medical, and regulatory officer April 25.

The first case with Medacta's MUST pedicle screw system and NextAR system was completed by Kevin McGuire, MD.

Spine and orthopedic devicemakers have made changes in their top leadership roles in 2022.

David Demski, CEO of Globus Medical, has resigned.

Minimally invasive spine device company Accelus is making a "strategic pivot" after it scrapped a previous deal to go public by merging with a special purpose acquisition company.

One hundred patients have been treated in an ongoing investigational device exemption clinical trial of Spineart USA's Baguera C cervical disc in the single level.

A study published in the Journal of Neurosurgery: Spine supports the effectiveness of NuVasive's Simplify cervical artificial disc at two levels compared to spinal fusion.

A spine company's $30 million investment and six more updates from spine and orthopedic device companies in the last week:

Robert Palmisano, who led Wright Medical, was added to Saluda Medical's board of directors.

AxioMed is progressing toward FDA approval for its viscoelastic for lumbar and cervical disc replacement, the devicemaker said April 19.